Danish researchers have received approval to conduct a vaccine trial in Guinea-Bissau that involves withholding the recommended hepatitis B vaccine from thousands of newborns. The study has drawn attention due to its association with Robert F. Kennedy Jr., who has publicly touted the research.
The trial is positioned as a significant component of a broader vaccine vision. By deviating from standard immunization protocols for newborns in the region, the study aims to investigate specific outcomes related to the administration of the hepatitis B vaccine.
In-depth summary · AI, neutral